- Home
- CISS vs SCNI Comparison
CISS vs SCNI Comparison
Compare CISS & SCNI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CISS
- SCNI
- Stock Information
- Founded
- CISS 2022
- SCNI 2003
- Country
- CISS Greece
- SCNI Israel
- Employees
- CISS N/A
- SCNI N/A
- Industry
- CISS Marine Transportation
- SCNI Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- CISS Consumer Discretionary
- SCNI Health Care
- Exchange
- CISS Nasdaq
- SCNI Nasdaq
- Market Cap
- CISS 2.8M
- SCNI 3.2M
- IPO Year
- CISS N/A
- SCNI N/A
- Fundamental
- Price
- CISS $3.30
- SCNI $2.47
- Analyst Decision
- CISS
- SCNI
- Analyst Count
- CISS 0
- SCNI 0
- Target Price
- CISS N/A
- SCNI N/A
- AVG Volume (30 Days)
- CISS 121.3K
- SCNI 1.1M
- Earning Date
- CISS 08-21-2025
- SCNI 08-14-2025
- Dividend Yield
- CISS N/A
- SCNI N/A
- EPS Growth
- CISS N/A
- SCNI N/A
- EPS
- CISS N/A
- SCNI N/A
- Revenue
- CISS $38,174,754.00
- SCNI $658,000.00
- Revenue This Year
- CISS N/A
- SCNI N/A
- Revenue Next Year
- CISS N/A
- SCNI N/A
- P/E Ratio
- CISS N/A
- SCNI N/A
- Revenue Growth
- CISS N/A
- SCNI N/A
- 52 Week Low
- CISS $2.85
- SCNI $1.90
- 52 Week High
- CISS $23.25
- SCNI $8.92
- Technical
- Relative Strength Index (RSI)
- CISS 41.14
- SCNI 49.52
- Support Level
- CISS $3.20
- SCNI $2.15
- Resistance Level
- CISS $4.00
- SCNI $2.70
- Average True Range (ATR)
- CISS 0.37
- SCNI 0.22
- MACD
- CISS -0.03
- SCNI 0.01
- Stochastic Oscillator
- CISS 8.33
- SCNI 32.99
About CISS C3is Inc.
C3is Inc is a provider of international seaborne transportation services to dry bulk charterers, including major national and private industrial users, commodity producers and traders. The company owns and operates a fleet of two dry bulk carriers that transport major bulks such as iron ore, coal and grains, and minor bulks such as bauxite, phosphate and fertilizers. The total cargo-carrying capacity of our fleet is approximately 64,000 dwt.
About SCNI Scinai Immunotherapeutics Ltd.
Scinai Immunotherapeutics Ltd is a biopharmaceutical company with two complementary business units, one focused on in-house development of inflammation and immunology (I&I) biological therapeutic products beginning with a pipeline of nanosized VHH antibodies (NanoAbs) targeting diseases with large unmet medical needs, and the other a boutique CDMO providing services to help biotech companies efficiently bring their products to market by leveraging Scinai's drug development and GMP and non-GMP manufacturing capabilities for pre-clinical and clinical studies. The company generates maximum revenue from the provision of CDMO (Contract Development and Manufacturing Organization) services.